Comparing How Single Arm Phase II Trial Data Can Support Approval of Oncologics by European Health Technology Assessment Bodies
Abstract
Authors
R. Macaulay
R. Macaulay
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now